PREVACID NAPRAPAC 375 (COPACKAGED) Drug Patent Profile
✉ Email this page to a colleague
When do Prevacid Naprapac 375 (copackaged) patents expire, and what generic alternatives are available?
Prevacid Naprapac 375 (copackaged) is a drug marketed by Takeda Pharms Na and is included in one NDA.
The generic ingredient in PREVACID NAPRAPAC 375 (COPACKAGED) is lansoprazole; naproxen. There are fifty-six drug master file entries for this compound. Additional details are available on the lansoprazole; naproxen profile page.
Summary for PREVACID NAPRAPAC 375 (COPACKAGED)
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PREVACID NAPRAPAC 375 (COPACKAGED) at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for PREVACID NAPRAPAC 375 (COPACKAGED)
US Patents and Regulatory Information for PREVACID NAPRAPAC 375 (COPACKAGED)
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Takeda Pharms Na | PREVACID NAPRAPAC 375 (COPACKAGED) | lansoprazole; naproxen | CAPSULE, DELAYED REL PELLETS, TABLET;ORAL | 021507-003 | Nov 14, 2003 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for PREVACID NAPRAPAC 375 (COPACKAGED)
See the table below for patents covering PREVACID NAPRAPAC 375 (COPACKAGED) around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Germany | 3751845 | ⤷ Try a Trial | |
Japan | H0244473 | ⤷ Try a Trial | |
Hungary | 195210 | PROCESS FOR PRODUCING PYRIDINE DERIVATIVES AND PHARMACEUTICAL PREPARATIONS COMPRISING THESE COMPOUNDS AS ACTIVE SUBSTANCE | ⤷ Try a Trial |
South Africa | 8506117 | ⤷ Try a Trial | |
Canada | 1255314 | DERIVES DE 2-(PYRID-2-YL)-METHYLTHIO(OU METHYLSULFINYL)BENZIMIDAZOLE ET LEUR PREPARATION (2-(PYRID-2-YL)-METHYLTHIO(OR METHYLSULFINYL) BENZIMIDAZOLE DERIVATIVES AND THEIR PRODUCTION) | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for PREVACID NAPRAPAC 375 (COPACKAGED)
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0174726 | 93C0021 | Belgium | ⤷ Try a Trial | PRODUCT NAME: LANSOPRAZOLE; NAT. REG.: 150 S 539 F 4 19921119; FIRST REG.: FR 333 412.1 19901211 |
0174726 | SPC/GB94/011 | United Kingdom | ⤷ Try a Trial | SPC/GB94/011, EXPIRES: 20051210 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |